Editas stock jumps after Broad wins CRISPR patent fight – FierceBiotech
FierceBiotech |
Editas stock jumps after Broad wins CRISPR patent fight
FierceBiotech Shares in Editas Medicine rose 30% after the U.S. patent office sided with the Broad Institute in the legal tussle over CRISPR gene editing. The board ruled that the inventions claimed by the Broad and the University of California are distinct … |
